Brain α-endosulfine is manifold decreased in brains from patients with Alzheimer's disease: A tentative marker and drug target?

Neuroscience Letters

Volumn 310, Issue 2-3, 2001, Pages 77-80

  Kim, Seong Hwan ^a   Lubec, Gert ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Endosulfine; Alzheimer's disease; ATP sensitive potassium channel; Neurotransmitters release

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA ENDOSULFINE PROTEIN; BRAIN PROTEIN; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BRAIN; CEREBELLUM; CONTROLLED STUDY; DRUG TARGETING; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; NEUROBIOLOGY; NEUROTRANSMITTER RELEASE; POTASSIUM TRANSPORT; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; AGED; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BRAIN; DROSOPHILA PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES; POTASSIUM CHANNELS;

EID: 0035860434     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(01)02025-0     Document Type: Article

References (26)

1. α-Endosulfine, a new entity in the control of insulin secretion
2. + channel opener diazoxide enhances glutamatergic currents and reduces GABAergic currents in hippocampal neurons
3. Glucose modulates rat substantia nigra GABA release in vivo via ATP-sensitive potassium channels
4. The pharmacology of ATP-sensitive potassium channels
5. Differential expression of ARPP-16 and ARPP-19, two highly related cAMP-regulated phosphoproteins, one of which is specifically associated with dopamine-innervated brain regions
6. Role of glucose in regulating the brain and cognition
7. A synaptic potentials in rat midbrain dopamine neurons
8. Possible involvement of K(ATP) channels in the control of 5-HT neurons
9. ATP channel: Molecular cloning, expression and biological properties
10. ATP channels
11. Reconstitution of IKATP: An inward rectifier subunit plus sulfonylurea receptor
12. Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease
13. 3H] Vesamicol binding in human brain cholinergic deficiency disorders
14. Glucose, memory, and aging
15. Ion channel effects of antidiabetic sulfonylureas
16. Antidiabetic sulphonylureas stimulate acetylcholine release from striatal cholinergic interneruons through inhibition of K(ATP) channel activity
17. The significance of glucose turnover in the brain in the pathogenetic mechanisms of Alzheimer's disease
18. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
19. Alpha endosulfine is a novel molecule, structurally related to a family of phosphoproteins
20. Abnormal brain glucose metabolism in Alzheimer's disease, as measured by positron emission tomography
21. Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channels subunit expressed in pancreatic beta-cells, brain, heart and skeletal muscle
22. + channel
23. Brain glucose metabolism in Alzheimer's disease
24. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: A clinicopathologic study of 57 cases
25. Endosulfine, an endogeneous ligand for the sulfonylurea receptor: Purification and partial characterization from ovine brain
26. Endosulfine, endogenous ligand for the sulfonylurea receptor: Isolation from porcine brain and partial structural determination of the alpha form